These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 26896572)

  • 41. Explore the effects of Huang-Lian-Jie-Du-Tang on Alzheimer's disease by UPLC-QTOF/MS-based plasma metabolomics study.
    Sun LM; Zhu BJ; Cao HT; Zhang XY; Zhang QC; Xin GZ; Pan LM; Liu LF; Zhu HX
    J Pharm Biomed Anal; 2018 Mar; 151():75-83. PubMed ID: 29310050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic profiling of the effects of ginsenoside Re in an Alzheimer's disease mouse model.
    Li J; Liu Y; Li W; Wang Z; Guo P; Li L; Li N
    Behav Brain Res; 2018 Jan; 337():160-172. PubMed ID: 28927718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A UHPLC-TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model.
    Gong Y; Liu Y; Zhou L; Di X; Li W; Li Q; Bi K
    J Pharm Biomed Anal; 2015 Nov; 115():174-82. PubMed ID: 26210744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice.
    Xu YM; Lu FM; Xu HC; Zhang J; Hei SY; Qiu YH; Cai YF; Zhang SJ; Zhao M
    Rejuvenation Res; 2023 Jun; 26(3):105-115. PubMed ID: 37073462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS.
    Yang L; Liang J; Zheng Q; Zhou L; Xiong Y; Wang H; Yuan J
    Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS.
    Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X
    J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hippocampus and serum metabolomic studies to explore the regulation of Chaihu-Shu-Gan-San on metabolic network disturbances of rats exposed to chronic variable stress.
    Su ZH; Jia HM; Zhang HW; Feng YF; An L; Zou ZM
    Mol Biosyst; 2014 Mar; 10(3):549-61. PubMed ID: 24398477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic profiling of copper-laden hepatolenticular degeneration model rats and the interventional effects of Gandou decoction using UPLC-Q-TOF/MS.
    Cheng M; Wu H; Wu H; Liu X; Zhou A
    J Pharm Biomed Anal; 2019 Feb; 164():187-195. PubMed ID: 30390561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer's disease.
    Li H; Kang T; Qi B; Kong L; Jiao Y; Cao Y; Zhang J; Yang J
    J Ethnopharmacol; 2016 Feb; 179():162-9. PubMed ID: 26721223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and determination of the major constituents in Kai-Xin-San by UPLC-Q/TOF MS and UFLC-MS/MS method.
    Lv C; He B; Sui Z; Li Q; Bi K
    J Mass Spectrom; 2016 Jul; 51(7):479-90. PubMed ID: 27434806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro.
    Yan C; Yang S; Shao S; Zu R; Lu H; Chen Y; Zhou Y; Ying X; Xiang S; Zhang P; Li Z; Yuan Y; Zhang Z; Wang P; Xie Z; Wang W; Ma H; Sun Y
    J Ethnopharmacol; 2024 May; 326():117915. PubMed ID: 38360383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kai-Xin-San, a Chinese Herbal Decoction, Accelerates the Degradation of
    Wang N; Jia Y; Zhang B; Li Y; Murtaza G; Huang S; Liu X
    Evid Based Complement Alternat Med; 2020; 2020():3862342. PubMed ID: 32148540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.
    Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S
    Front Pharmacol; 2020; 11():381. PubMed ID: 32317964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress.
    Dang H; Sun L; Liu X; Peng B; Wang Q; Jia W; Chen Y; Pan A; Xiao P
    Exp Biol Med (Maywood); 2009 Jul; 234(7):785-93. PubMed ID: 19429857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. UPLC-ESI-IT-TOF-MS metabolomic study of the therapeutic effect of Xuefu Zhuyu decoction on rats with traumatic brain injury.
    Fu C; Wu Q; Zhang Z; Xia Z; Ji H; Lu H; Wang Y
    J Ethnopharmacol; 2019 Dec; 245():112149. PubMed ID: 31401321
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Xu YM; Wang XC; Xu TT; Li HY; Hei SY; Luo NC; Wang H; Zhao W; Fang SH; Chen YB; Guan L; Fang YQ; Zhang SJ; Wang Q; Liang WX
    Neural Regen Res; 2019 May; 14(5):794-804. PubMed ID: 30688265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
    Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
    Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach.
    Zhang A; Sun H; Han Y; Yuan Y; Wang P; Song G; Yuan X; Zhang M; Xie N; Wang X
    Analyst; 2012 Sep; 137(18):4200-8. PubMed ID: 22852134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.